Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Presentations 12:30 - 13:30

Thursday Julv ii

[PpAO4 Immunity and Immune Reconstitution
Poster Presentation
Venue: Palacio 4 - A corner
Date: Thursday, July 11, 2002
Time: 12:30- 13:30
Chairs: Guido Poli, Italy
Maite Suarez, Spain

12:30 ThPpA2127

12:40 ThPpA2128
12:50 ThPpA2129
13:oo ThPpA213o
13:o10 ThPpA2131
13:20 ThPpA2132

Genetic determinants of immune restoration
diseases in HIV-1 patients receiving highly
active anti-retroviral therapy
P Price, G Morahan, L Abraham,
MA French (Australia)
Novel dendritic cell-based topical DNA
vaccination combined with STI-HAART
induced immune control in macaques
with AIDS
J Lisziewicz, ]JXu', M Lewis', ] Trocio,
L Whitman', F LorP ('United States; 2Italy)
Evaluation of immune restoration parameters in antiretroviral therapy (ART)
naive patients: role of the thymus in
naive T cell rise (COLA300oo3 Study)
L Al-Harthi, J Voris, S Becker, J Eron,
K Smith, R D'Amico, D Mildvan, J Snidow,
B Pobiner, L You, A L Landay (United States)
Cytotoxic T cell recognition of HIV-1
cross-clade and clade-specific epitopes
in HIV-i-infected Thais and Japanese
K Fukada', H Tomiyama, C Wasi2P,
T Matsuda', S Ida, S Kusagawa,
H Sato', S Oka', Y Takebe1, M Takiguchi1
('Japan; 2Thailand)
To be announced
CD4 cell depletion, immune activation
and viral load in HIV infection: from correlations to causal relationships
Z Grossman A E Sousa2, R M M Victorino2
( United States; 2Portugal)

13:oo ThPpB2136
13:10 ThPpB2137
13:2o ThPpB2138

Diagnostic value of measurement methods of adherence to HAART in HIV-infected persons
A Deschamps, V De Saar', V De Graeve,
E Van Wijngaerden', A - M Vandamme',
K Van Vaerenbergh', H Ceunen',
H Bobbaers', S De Geest2
(Belgium; 2Switzerland)
Dynamic of adherence to antiretroviral
therapy and its impact on virological and
immunological response after 3 years of
treatment
B Spire, P Carrieri, VJournot, H Portier,
CV Cailleton, V Chain, C Leport,
P Massip, I P Moatti, FRaffi (France)
Failure to maintain adherence to HAART
in a cohort of French HIV-infected injecting drug users
P Carrieri', MA Chesney2, B Spire',
A Loundou', A Sobel', G Lepeu,
I P Moatti ('France; 2United States)

PC4 HIV Disease Progression and Impact
Poster Presentation
Venue: Palacio 4 - C corner
Date: Thursday, July 11, 2002
Time: 12:30 - 13:30
Chairs: Julia del Amo, Spain
Jesus Castilla, Spain

12:30 ThPpC2139

12:40 ThPpC214o
12:50 ThPpC2141

[PPB04 Adherence and Quality of Life
Poster Presentation
Venue: Palacio 4 - B corner
Date: Thursday, July 11, 2002
Time: 12:30 - 13:30
Chairs: Jorge Beloqui, Brazil
Rodrigo Pascal, Chile

12:3o ThPpB2133

Thursday 12:4o ThPpB2134
12:50 ThPpB2135

Effect on patients' quality of life (QoL) of
starting HAART at different CD4 cell counts
P T Nieuwkerk, M E Hillebrand,
R Vriesendorp, PH ] Frissen, F de Wolf,
j MA Lange, MA G Sprangers
(The Netherlands)
Physical and psychological impacts of
structured treatment interruptions
M L B Le Braz C FFagard, CS Schneider,
V W Werder, J V Voggensperger,
D T Toscano, A C Christen, S G Gallant,
H W Weyermann, M R Russoti, B H Hirschel
(Switzerland)
Quality of life and emotional status of HIV1+ patients with viral load suppression in
structured treatment interruptions
CR Fumaz A Tuldra, M J Ferrer,
M Barceld, I Miranda, J C Martifnez,
L Ruiz, B Clotet (Spain)

13:oo ThPpC2142
13:10 ThPpC2143
13:2o ThPpC2144

Child survival and mother's HIV status in
a rural Ugandan cohort
JS Nakiyingi', jA G Whitworth',
A Ruberantwari', J Busingye',
SM Mbulaiteye2, B Zaba3 ('Uganda;
2United States; 3United Kingdom)
Monitoring the situation of orphans, a
global assessment
CR Monasch R Venu (United States)
The longterm impact of HIV and orphanhood on the mortality and well-being of
children in rural Malawi
A C Crampin', S Flod2, j R Glynn2,
N] J Madise2, A Nyondo',
M M Khondowe', CL Njoka',
H Kanyongoloka', B Ngwira', B Zaba2,
P EM Fine 2 ('Malawi; 2United Kingdom)
Linking hospital HIV sero-survey data to
discharge records: impact of HIV/AIDS at
Lacor Hospital, North Uganda (1992-1998)
S Accorsi, M Fabiani', G Rizzardini,
M Lukwiya2, M G Dente', C Opira2,
R Aleni2, S Declich' (ltaly; 2 Uganda)
The predominance of HIV-1 CRFo2_AG in
west and west central Africa is not related to difference in pathogenesis: a fouryear prospective multicentre study
A Bourgeois', C Laurent', M A Faye2
R Mougnutou3, M SeydP, M Gueye2
F Liegeois', C Toure Kane2, C Butel,
J Mbuagbaw, L Zekeng3, E Mpoudi
Ngole3, M Peeters', E Delaporte'
('France; 2Senegal; 3Cameroon)
Impact of HIV-1 viral subtype on disease
progression
P Easterbrook M Smith, A M Geretti,
N Osner, S Murad, S Oshea, I Chrystie,
J Mullen, A M de Ruiter, M Zuckerman,
G K T HIV Virology Collaborative group
(United Kingdom)

212 Final Program